Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The project is part of a three-year-long partnership between Honeywell and Americares to strengthen the health infrastructure in rural Maharashtra, Uttarakhand and Haryana
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Subscribe To Our Newsletter & Stay Updated
